Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« The Human Brain Project | Main | A Personal Perspective on Neurotechnology »

April 23, 2003

Neurotechnology before Genetic Engineering

Email This Entry

Posted by Zack Lynch

Bill McKibben's brave new book, Enough: Staying Human in an Engineered Age explores (excerpt) how human genetic technologies will soon give scientists the ability to re-engineer our children, undermining our common humanity, and leading to a 'posthuman' future.


The human germ-line engineering debate continues to capture the popular imagination, sitting at the core of bioethics debates, while neurotechnology quickly slips into existence.


It is my firm belief that neurotechnology's ability to provide tools that can temporarily influence human emotional, cognitive and sensory states via neuroceuticals will have more profound implications for humanity, in a much nearer time frame, than genetic engineering for several reasons:



  • Regulation and distribution systems are in place:  The FDA and pharmaceutical development and distribution systems are already globally refined, tested and trusted processes
  • Social acceptance is proven: Humans are already using early forms of neuroceuticals on a vast scale.  For example, 17% of the US white-collar work force is currently using anti-depressants. 

Humans will perform germ-line engineering on other organisms on vast scale, but human germ-line engineering won't become widely accepted until significant experimentation with less permanent tools helps people learn exactly what traits they would want their progeny to exhibit. 


Moreover, as neurotechnology becomes more precise and flexible, it may indeed turn out that humans will choose neurotechnology over genetic engineering to enhance themselves and their offspring.  Instead of debating the bioethics of germ-line engineering, we really should be focusing on the neuroethics of neurotechnology.

Comments (0) | Category: NeuroWave 2050 | Neurosociety



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives